HAEM4:Enteropathy-Associated T-cell Lymphoma: Difference between revisions
Bailey.Glen (talk | contribs) Created page with "==Primary Author(s)*== *Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD __TOC__ ==Cancer Category/Type== *Mature T- and NK-cell Neoplasms ==Cancer Sub-Classification..." |
Bailey.Glen (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Enteropathy-Associated T-cell Lymphoma}} | |||
<blockquote class='blockedit'>{{Box-round|title=PREVIOUS EDITION|This page from the 4th edition of Haematolymphoid Tumours is being updated. See 5th edition [[HAEM5:Table_of_Contents|Table of Contents]]. | |||
}}</blockquote> | |||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
| Line 7: | Line 12: | ||
==Cancer Category/Type== | ==Cancer Category/Type== | ||
*[[Mature T- and NK-cell Neoplasms]] | *[[HAEM4:Mature T- and NK-cell Neoplasms]] | ||
==Cancer Sub-Classification / Subtype== | ==Cancer Sub-Classification / Subtype== | ||
*[[Intestinal T-cell Lymphoma|Intestinal T-cell lymphoma]] | *[[HAEM4:Intestinal T-cell Lymphoma|Intestinal T-cell lymphoma]] | ||
==Definition / Description of Disease== | ==Definition / Description of Disease== | ||
| Line 96: | Line 101: | ||
****Flow cytometry: sCD3<sup>_</sup>, CD8-, CD5- | ****Flow cytometry: sCD3<sup>_</sup>, CD8-, CD5- | ||
****IHC: | ****IHC: | ||
*****NKP46: significantly more positive in RCD2 IEL than normal IEL in CD and RCD1; not specific for RCD2 or EATL, can be seen in [[Monomorphic | *****NKP46: significantly more positive in RCD2 IEL than normal IEL in CD and RCD1; not specific for RCD2 or EATL, can be seen in [[HAEM5:Monomorphic epitheliotropic intestinal T-cell lymphoma|MEITL]]; not seen in [[HAEM5:Indolent T-cell lymphoma of the gastrointestinal tract|indolent T-cell LPD of GI tract]] | ||
*****CD30+ indicates progression to EATL | *****CD30+ indicates progression to EATL | ||
**** | **** | ||
| Line 307: | Line 312: | ||
==Links== | ==Links== | ||
*[[Intestinal T-cell Lymphoma]]<nowiki/>s | *[[HAEM4:Intestinal T-cell Lymphoma]]<nowiki/>s | ||
*[[Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropi]]<nowiki/>[[Monomorphic epitheliotropic intestinal T-cell lymphoma|c intestinal T-cell lymphoma]] | *[[Monomorphic epitheliotropic intestinal T-cell lymphoma|Monomorphic epitheliotropi]]<nowiki/>[[Monomorphic epitheliotropic intestinal T-cell lymphoma|c intestinal T-cell lymphoma]] | ||
| Line 318: | Line 323: | ||
==Notes== | ==Notes== | ||
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | ||
[[Category:HAEM4]] [[Category:DISEASE]] | |||